Introduction
Somatic symptoms are ubiquitous in the general population; an estimated 80% of individuals will experience one or more somatic symptoms in any given month [1] .
Symptoms may include pain as well as digestive, cardiovascular, pulmonary, urological, neurological, or sensory complaints. Many symptoms are neither exclusive correlates of an organic disease (e.g. cancer or coronary heart disease) nor exclusive symptoms of a psychiatric condition (e.g. depression or anxiety disorders) [2] [3] [4] . Somatic symptoms which are either part of a functional somatic syndrome, or otherwise unexplained by pathology, are the reason for at least 33% of primary care consultations and between 15 and 54% of specialist referrals across many medical disciplines. Usually, only those individuals who are actually distressed or impaired by their somatic symptoms present to clinical practice. About one fourth of all patients develops persistent symptoms [5] .
Persistent somatic symptoms usually represent a substantial burden, they significantly impair patients' quality of life and level of functioning. Psychological factors like depression or anxiety as well as symptom-specific concerns or expectations are important contributors to high levels of health care use in these patients [6] . Repeated investigations and hospital treatment are frequent consequences and lead to high socio-economic costs. The health care burden due to persistent somatic symptoms is comparable to anxiety and depressive disorders, and there is a high co-morbidity between these disorders [7, 8] . Strategies to improve the early recognition and identification of patients with high somatic symptom burden is important to initiate adequate treatment [9] .
Standardized patient-reported outcome measures like self-report questionnaires are a good option to assess, quantify, and monitor common conditions in clinical, and especially in general practice. A frequent challenge in this context is to make precise assessments within a limited amount of time. Additionally, self-report represents a complementary source of information by capturing the patients' own perspectives of their symptoms [10] .
A C C E P T E D M A N U S C R I P T
From a research perspective, it is important to assess the number, type and severity of somatic symptoms as change in symptoms will continue to be a central outcome feature of treatments for patients and physicians/therapists alike [11] . There are several standardized and validated instruments which effectively measure the patients' burden due to specific somatic complaints (e.g. PHQ-15 [12] , SSS-8 [13] , SCL-90R or BSI [14] ).
The Patient Health Questionnaire PHQ-15 is one of the most frequently used instruments to identify people at risk for somatization. It has well-established psychometric properties, is available in multiple languages and has been recommended for use in largescale studies [15] . The PHQ-15 assesses the presence and severity of common somatic symptoms in primary care, such as fatigue, gastrointestinal, musculoskeletal, pain, and cardiopulmonary symptoms within the last four weeks using 15 items. Sum-scores range from 0 to 30 and indicate the self-rated symptom burden with higher scores indicating higher burden (0-4 no-minimal; 5-9 low; 10-14 medium; 15-30 high).
The Somatic Symptom Scale-8 (SSS-8) was developed within the process of the DSM-5 field trials as a measure of somatic symptom burden related to the new diagnosis of somatic symptom disorder (former title: Patient Health Questionnaire Somatic Symptom Short-Form, PHQ-SSS) [16] . It is an abbreviated 8-item version of the PHQ-15. The items of the SSS-8 were selected on the basis of symptom prevalence in primary care, association with measures of functioning, and statistical commonalities with the items of the complete scale.
Some original items were condensed from two into one, and a few items were deleted. A 5-point response option (0-4) for each SSS-8 item and a 7-day time frame are used. Cut-offscores indicate whether a patient suffers from minimal (0-3 points), low (4-7), medium (8-11),
high (12) (13) (14) (15) , or very high (16-32) somatic symptom burden. Gender and age specific norms are available [13] . Previous studies demonstrated good item characteristics and excellent reliability, a sound factor structure and significant associations with related constructs like depression, anxiety, quality of life, and health care use [13, 17] . The SSS-8 is available in
English, German, and Japanese [13, 17, 18] , and its sensitivity to change has recently been demonstrated [19] .
Aims of the study
Gierk and colleagues [17] examined within a sample of outpatients from a psychosomatic clinic in Germany whether both measures were comparable in terms of their psychometric properties and estimates of symptom burden. The correlation between both instruments was high (r = 0.83) and they showed similar results considering reliability and validity. The SSS-8 performed well as a short version of the PHQ-15. Also, analyses suggested that similar cut-points might be used for both measures in grading somatic symptom burden as mild, moderate or severe. The aim of this paper is to replicate and extend the psychometric comparison of both measures using baseline data from a large clinical trial.
Specifically, we compare the two measures in terms of item characteristics, reliability, and construct validity of the severity thresholds with regard to health related quality of life, functional impairment and work disability. 
Method

Procedure and participants
Data
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Somatic symptom measures
The CAMMPS trial used a modified, 14 item version of the PHQ-15, hereinafter referred to as the PHQ-15m. The item on sexual pain and problems was left out for several reasons. First, it is the least commonly endorsed item in multiple epidemiological studies and also the one item that a subset of respondents are most uncomfortable answering. Second, the item has shown the lowest item-total correlation (0.33) of any of the PHQ-15 items, and all correlations with other items of the scale were low (<.20). Third, this item demonstrates among the lowest correlations with multiple domains of quality of life, disability and health care use. Fourth, in factor analysis, this item and the item on menstrual problems had the lowest commonality with the other 13 items and were excluded from the three factors (cardiopulmonary, gastrointestinal, and fatigue/pain) [12] . Fifth, reliability in terms of internal consistency (Cronbach α) for the modified 14 item version (PHQ-15m) ranged from 0.76 -0.77 in three large clinical trials [20] [21] [22] , which is similar to the reliability reported for the original PHQ-15 (Cronbach α = .80 [12] ). Finally, these trials demonstrated the responsiveness to treatment of the PHQ-15m. The Somatic Symptom Scale-8 (SSS-8) was used in its original form [13] .
Other Mental Health, Quality of Life and Disability Measures
Depression was measured with the Patient Health Questionnaire 9-item depression scale (PHQ-9; [23] which assesses the presence of the nine DSM criteria for major depression within the last two weeks. Scores range from 0 to 27 and indicate the severity of depression (high scores reflect high symptom load).
Anxiety was assessed with the7-item Generalized Anxiety Disorder Scale (GAD-7)
[24], a self-administered patient questionnaire which is used as a screening tool and severity measure of both generalized anxiety disorder as well as other common anxiety disorders.
Scores range from 0 (minimal) to 21 (severe).
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The Brief Pain Inventory (BPI) [25] is an 11-item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. Patients are asked to rate their worst, least, average, and current pain intensity, , and the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on a 0 (none) to 10 (worst) . We used the mean total pain score for our analyses. The Sheehan Disability Index (SDI) [27] assesses functional impairment in three interrelated domains: work/school, social and family life. Each of its 3 items is scored from 0 (unimpaired) to 10 (highly impaired), with the SDI score being a mean of the 3 items.
In addition, patients reported the number of days in the past four weeks where they had to reduce their usual activities by 50% or more (range: 0 to 28), and provided information on sociodemographic characteristics.
Statistical Analyses
Because the PHQ-15 and SSS-8 were interviewer-administered, the amount of missing data at the item level was very low (1-2%) and comparable for both scales. To provide a conservative estimate of the scale score, a missing item was assigned a value of 0. We calculated means, standard deviations, corrected item-total-correlations and frequency distribution of responses per item for the PHQ-15m and the SSS-8. Reliability was assessed using Cronbach´s α. Pearson correlations between the PHQ-15m, SSS-8, PHQ-9, GAD-7, BPI, MCS, PCS, SDI and disability days were calculated. Percentile distributions of somatic symptom severity for the PHQ-15m and the SSS-8 were calculated. Incidence rate ratios
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(IRR) for each 1-point change in PHQ-15m and SSS-8 in association with change in disability days were calculated using parameter estimates from negative binomial regression. In terms of clinically important differences, 1-and 2-standard error of measurement (SEM) changes in PHQ-15m and SSS-8 were calculated (where SEM = standard deviation times the square root of 1-Cronbach's alpha) to quantify the increase in disability days that is associated with change in somatic symptom burden [28] . To study the comparability of the severity thresholds of both scales, we calculated the mean (SD) physical health-related quality of life (PCS), functional impairment (SDI) and disability days for groups of patients that were classified according to the different PHQ-15m and SSS-8 scoring cut-points. We quantified the between-scale differences using the standardized mean difference (Cohen´s d). Table 1 reports sociodemographic and psychopathological characteristics of the study sample. Participants had a mean age of 57.4 and were 87% male and 79% white, characteristic of a Veteran population. Symptom and quality of life scores were in the moderate to moderately severe range as expected for patients with chronic pain and psychiatric comorbidity.
Results
Study sample
Psychometric characteristics of PHQ-15m and SSS-8
The mean (SD) sum-scores of the PHQ-15m and the SSS-8 were 16.7 (5.8) and 13.5 (4.1), respectively. The correlation between the two scales was 0.79. The internal consistencies were α = 0.66 for the PHQ-15m and α = 0.72 for the SSS-8. As shown in Table   2 , the mean score for specific symptoms varied in both scales, which indicates that some somatic symptoms are reported more frequently and/or at a higher severity level than other symptoms. Pain, energy and sleep items had the highest mean scores, whereas dizziness had the lowest scores. Considering the differing response formats of both scales, frequency distributions of responses are comparable, with the items on chest pain and/or shortness of
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breath being the least comparable. All corrected item-total correlations were > 0.50 for the SSS-8; several were lower (< 0.40) for the PHQ-15m.
Association of somatic symptom burden with psychopathology, health-related quality of life,
and disability.
The PHQ-15m and the SSS-8 sum-scores were highly correlated (r = 0.79). As shown in Table 3 , both scales showed a similar pattern of correlations with self-report measures of depression, anxiety, pain (BDI), physical and mental health-related quality of life, functional impairment, and disability days (CUTPH): Higher scores on the PHQ-15m and SSS-8
correspond to higher levels of depression, anxiety, pain, functional impairment and disability days and lower levels of physical and mental health-related quality of life.
Percentile distribution of PHQ-15m and SSS-8 scores
Although the PHQ-15m and the SSS-8 have different numbers of items and a different response format, the sum-scores of both scales have a similar percentile distribution which is shown in Table 4 . The comparability in the distribution is high (difference ≤ 3 points) up to the 50 th percentile, however, it steadily decreases from the 60st percentile (difference = 4 points) to the 99 th percentile (difference = 8 points).
Association of somatic symptom scores with disability days
Patient-reported number of disability days in the past four weeks (i.e., number of days and 26.3% increase in disability days, respectively.
Comparing two ways of classifying severity cut-points on the SSS-8
To examine the comparability of the PHQ-15m and the SSS-8 severity categories, we compared -in accordance with Gierk et al. [17] -the physical health-related quality of life (SF-12 PCS) scores of patients who were grouped by the standard PHQ-15m severity thresholds and two ways of classifying SSS-8 severity thresholds. We additionally compared the groups with regard to their Sheehan Disability Index scores and number of disability days.
To quantify the between-scale differences on these three outcomes, we calculated the Additionally the standard PHQ-15m thresholds were applied to the SSS-8 (0-4 no-minimal; 5-9 low; 10-14 medium; ≥ 15 high). Only two of the patients from our sample fell within any of the groups of no -minimum symptom burden, so that the results for this threshold group is not displayed. All other results are shown in Table 5 . For all three outcomes, grouping patients according to the original SSS-8 severity thresholds led to higher group differences between the PHQ-15m and SSS-8 than using the PHQ-15m severity thresholds for the SSS-8.
There are, however, two exceptions: in the low category for the SF-12 PCS and in the medium category for the SDI, the SSS-8 original scoring method led to smaller differences.
Discussion
The main aim of the study was to compare the psychometric properties of two instruments assessing somatic symptom burden: the PHQ-15 and the SSS-8. In an earlier
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study, Gierk et al. [17] found comparable reliability and construct validity for both measures and therefore suggested the use of the SSS-8 as a more efficient alternative to the original PHQ-15, especially in clinical settings with limited assessment time or in research settings to reduce the measurement burden for study participants. Since the original study was based on a fairly small and selective sample of patients, the findings regarding alternative severity thresholds for the SSS-8 were considered preliminary. We used the PHQ-15m and SSS-8 The frequency distributions of responses, the mean item severity of specific symptoms, and the standard deviations within the scales were comparable considering the differing response formats of both scales. For both scales, the highest average scores were found for items on pain, energy and sleep which could be expected in a trial on mood and pain symptoms. The lowest average scores were found for dizziness. The items on chest pain
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and/or shortness of breath showed the least comparable results which may be due to the fact that they have been combined into a single item in the SSS-8. Both items may be more relevant for patients with burdensome cardiopulmonary symptoms which were not the focus of our study. All item-total correlations were lower for the PHQ-15m which may in general be due to the heterogeneous latent structure of somatic symptom burden [29] which is even more salient to the PHQ-15m which consists of more items.
The correlation between the SSS-8 and the PHQ-15m was high (0.79) and comparable to the findings by Gierk et al (0.83). Both measures showed substantial positive associations with depression and anxiety which is expected since there are high comorbidities between somatoform disorders and depression and anxiety disorders [8] . Associations with the Brief Pain Inventory (BPI) were similar and also substantial which is not surprising given the item overlap with regard to pain. Burdensome somatic symptoms are usually associated with decreased health-related quality of life, reduced daily activities and increased disability across different life domains [30, 31] . With regard to physical and mental health-related quality of life, both the PHQ-15m and SSS-8showed a substantial negative association (i.e. high symptom burden corresponded to poor health-related quality of life). Associations were substantially positive with respect to disability (i.e. high symptom burden corresponded to high impairment). When comparing the correlations of the PHQ-15 and SSS-8 with measures that were used in both Gierk's study and our trial (GAD-7 anxiety, PHQ-9 depression, SF mental and physical health-related quality of life), correlations found in our study were slightly lower, with the SSS-8 showing higher associations than the PHQ-15m with all used.
Looking at the percentile distributions, the comparability in the two scales was high up to the 50th percentile (difference ≤ 3 points) and steadily decreased from the 60st percentile on (differences between 4 and 8 points). These differences are greater than the ones found in Gierk et al [17] . Similar to Gierk et al., we found substantial differences in the severity estimation of the PHQ-15m and SSS-8 severity thresholds which could in general be reduced
by scoring the SSS-8 with the PHQ-15 thresholds. This supports a good correspondence between the SSS-8 and the PHQ-15m with data from a larger sample of patients from primary care, not only on the dimension of physical health-related quality of life, but also when measuring physical impairment (SDI) and disability days.
Our study has a few limitations. First and for reasons discussed earlier, we used a modified version of the PHQ-15, the PHQ-15m, which limits the direct comparability of our study results to the ones found in Gierk et al. However, we would assume that the exclusion of the item on sexual pain and problems in the PHQ-15m makes both instruments more comparable since this particular item is not included in the SSS-8. Since it is also one of the items least endorsed, the average PHQ-15 sum-score should not be noticeably influenced by excluding this item. Second, our study uses baseline data only, so that longitudinal questions like the effects of the different time frames of the PHQ-15m (i.e. symptom burden within the last 4 weeks) and the SSS-8 (i.e. symptom burden within the last 7 days) cannot be answered.
Due to feasibility reasons, both questionnaires were presented to the patients at baseline as part of an interview-based set of measures. The PHQ-15m was administered first in all patients, so that possible carry-over effects cannot be excluded.
Altogether the SSS-8 performed well as a brief measure of somatic symptom burden in primary care patients with mood and pain symptoms. Its psychometric properties were similar or even slightly better (i.e. higher correlations with other measures) than those of the PHQ15m. Taking into account all three different impairment measures, the estimates of symptom burden were very similar when the SSS-8 was scored with the PHQ-15 thresholds. Our results therefore support the idea of common scoring thresholds for both instruments. Since there is a growing impetus to incorporate patient-reported outcome measures into clinical practice [32] with the simultaneous need to consider competing demands for treating and managing many different acute and chronic conditions in clinical practice, our findings provide further support for the utility of the SSS-8 as a short measure for somatic symptom burden. 
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The SSS-8 asks how much a symptom bothered the patient in the past week; each item is scored from 0 (not at all) to 4 (very much). A C C E P T E D M A N U S C R I P T 
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